Virax Biolabs Group Limited Ordinary Shares
Price & Volume
Stats
See moreOpen | $2.82 |
Previous Close | $2.73 |
Day Range | $2.82-$2.83 |
52W Range | $2.50-$21.75 |
Market Cap | $2M |
Shares Short | 23,357 |
Financials
See moreRevenue (12 Mos) | $12,423 |
Revenue Growth (YoY) | 684.9% |
Gross Profit (12 Mos) | $7,690 |
Diluted EPS | -$12.64 |
News
See moreYahoo Finance • 2 months ago
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
Yahoo Finance • 2 months ago
Virax Biolabs enters immune profiling product supply deal with Fosun
Yahoo Finance • 2 months ago
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
Yahoo Finance • 2 months ago
Virax Signs Multi-Country Commercial Supply Agreement With Fosun Diagnostics; Stock Skyrockets
About
CEO | Mr. James Foster |
Address | BioCity Glasgow, Lanarkshire, United Kingdom, ML1 5UH |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 26 |